Role of synaptotagmin 13 (SYT13) in promoting breast cancer and signaling pathways.
Yi-Dan ZhangRui ZhongJin-Quan LiuZhen-Xuan SunTeng WangJin-Tao LiuPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
The results indicated that SYT13 promoted the malignant phenotypes of breast cancer cells by the activation of FAK/AKT signaling pathway.